Micronutrient Deficiencies on GLP-1 Inhibitors Individuals taking GLP-1 inhibitors may be at risk for certain micronutrient deficiencies, primarily due to reduced appetite leading to lower food intake
In a review study from Denmark, also analyzed by Fessel, dementia risk was lowered by 53% when patients with Type 2 diabetes on GLP-1s were compared to patients on placebo
At the core of this formula lies high-purity Glutathione (50,000ppm, 99.4% purity), a master antioxidant renowned for combating excess melanin and signs of oxidative stress
Zepbound is a combination of GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), with research showing people lost an average of 20.9% of their weight in 72 weeks on the highest dose
Key Highlights 1 A New Mechanism Trifunctional Effector Cell Response Inhibitors (ECRIs) Unlike conventional IgE-targeting drugs such as Novartis and Sanofis #Xolair, which block only free IgE, Excellergys ECRIs are designed to: Neutralize and remove IgE antibodies, Dislodge IgE already bound to immune cell receptors, and Downregulate FceRI receptor expression, reducing allergic reactivity at its source
reached similar conclusions through further research, demonstrating that hypoxia induces VEGF-A secretion in uterine fibroid cells [19]
